arrow
E

Eugène McCloskey

University of Sheffield
H指数:103
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pregnancy- and lactation-associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS

妊娠和哺乳相关骨质疏松症:IAPM、IOF、ECTS、ESCEO、IMS和EMAS的立场声明

2026-09-300
OAAI
Vitamin D in coronary heart disease: a Mendelian randomization meta-analysis of data stratified by 25(OH)D levels

维生素D在冠状动脉心脏病中的作用:一项按25(OH)D水平分层的孟德尔随机化Meta分析

2026-09-220
PRE
Health-related quality of life instruments for older persons with osteoporosis: a WHO-BOHEG systematic review of measurement properties for use in clinical trials and routine practice

骨质疏松老年患者健康相关生活质量量表:WHO-BOHEG关于测量属性的系统评价,用于临床试验和常规实践

2026-05-010
PRE
Forearm BMD predicts fracture independently of FRAX

前臂骨密度独立于FRAX预测骨折

2026-04-230
PRE
Correction: Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX

更正:BMD对髋部及其他骨折的预测价值:一项用于更新FRAX的荟萃分析

2026-04-010
PRE
Correction: A meta-analysis of previous falls and subsequent fracture risk in cohort studies

更正:对队列研究中先前跌倒和随后骨折风险的荟萃分析

2026-03-240
PRE
A meta-analysis of smoking and fracture risk to update the FRAX® tool

吸烟与骨折风险的Meta分析,以更新FRAX®工具

2026-03-040
PRE
Author Correction: Parathyroid hormone receptor agonists in the management of osteoporosis

作者更正:甲状旁腺激素受体激动剂在骨质疏松症管理中的应用

2025-09-300
OAAI
Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment tool

骨折家族史与骨折风险:一项更新FRAX®风险评估工具的荟萃分析

2025-08-230
PRE
Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation

全球骨质疏松症管理获取的障碍与解决方案:国际骨质疏松基金会立场文件

2025-08-220
OAAI
Parathyroid hormone receptor agonists in the management of osteoporosis

甲状旁腺激素受体激动剂在骨质疏松症管理中的应用

2025-08-110
PRE
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

骨转换标志物在骨质疏松症诊断和管理中的作用的更新: 欧洲骨质疏松症,骨关节炎和肌肉骨骼疾病临床和经济方面学会 (ESCEO),国际骨质疏松症基金会 (IOF) 和国际临床化学和实验室医学联合会 (IFCC) 的共识论文

2025-03-281
OA
Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX

类风湿关节炎与后续骨折风险:一项用于更新FRAX的个体患者数据Meta分析

2025-02-160
PRE
Body mass index and subsequent fracture risk: a meta-analysis to update FRAX

Harvey, N.C.; Johansson, H.; McCloskey, E.V.; Liu, E.; Åkesson, K.E.; Anderson, F.A.; Azagra-Ledesma, R.; Bager, C.L.; Beaudart, C.; Bischoff-Ferrari, H.A.; 等. 体重指数与后续骨折风险:一项用于更新FRAX的Meta分析. J. Bone Miner. Res. 2025, 40, 1144–1155. [Google Scholar] [CrossRef]

2025-01-010
OAAI
Impact of dementia and mild cognitive impairment on bone health in older people
2024-12-270
OAAI